GEODE CAPITAL MANAGEMENT, LLC - MONOPAR THERAPEUTICS INC ownership

MONOPAR THERAPEUTICS INC's ticker is MNPR and the CUSIP is 61023L108. A total of 14 filers reported holding MONOPAR THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of MONOPAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$23,483
-34.4%
41,199
-1.7%
0.00%
Q2 2023$35,817
-39.8%
41,8920.0%0.00%
Q1 2023$59,486
+59986.9%
41,8920.0%0.00%
Q4 2022$99
-99.8%
41,892
+6.9%
0.00%
Q3 2022$59,000
-30.6%
39,1710.0%0.00%
Q2 2022$85,000
-15.0%
39,1710.0%0.00%
Q1 2022$100,000
-20.6%
39,1710.0%0.00%
Q4 2021$126,000
-33.3%
39,1710.0%0.00%
Q3 2021$189,000
+11.8%
39,171
+36.2%
0.00%
Q2 2021$169,000
+3.7%
28,761
+9.0%
0.00%
Q1 2021$163,00026,3940.00%
Other shareholders
MONOPAR THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
American Portfolios Advisors 700$1,6100.00%
ROYAL BANK OF CANADA 4,116$9,0000.00%
VANGUARD GROUP INC 99,879$230,0000.00%
UBS Group AG 19,561$45,0000.00%
IFP Advisors, Inc 500$13,0000.00%
FMR LLC 10$00.00%
WELLS FARGO & COMPANY/MN 29$00.00%
NORTHERN TRUST CORP 35,203$81,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 39,171$85,0000.00%
View complete list of MONOPAR THERAPEUTICS INC shareholders